Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Australasian Leukaemia and Lymphoma Group (ALLG)
Scientific Title
A Phase II Study of Ibrutinib, Rituximab and mini-CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) therapy in very elderly patients with newly diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)